The past decade has seen numerous drugs come “off patent” and a consequent increase in the number of generic products seeking approval.

In April 2012 the International Generic Drug Regulators Programme (IGDRP) instigated a pilot programme for the shared evaluation of generic applications. The European Decentralised Procedure (DCP) was used as the model for data […]